Minimally Invasive Liver Surgery
Cross-source consensus on Minimally Invasive Liver Surgery from 1 sources and 5 claims.
1 sources · 5 claims
Uses
Benefits
Comparisons
Evidence quality
Highlighted claims
- Achieving R0 resection in hepatic surgery is strongly associated with patient survival. — Indocyanine green fluorescence for intraoperative detection of liver tumours in minimally invasive surgery: protocol for the LIVERGREEN phase IV multicentre clinical trial
- Standard liver surgery planning and intraoperative decision tools include CT, MRI, PET-CT, and intraoperative ultrasound. — Indocyanine green fluorescence for intraoperative detection of liver tumours in minimally invasive surgery: protocol for the LIVERGREEN phase IV multicentre clinical trial
- Existing standard imaging and intraoperative tools have imperfect sensitivity and specificity. — Indocyanine green fluorescence for intraoperative detection of liver tumours in minimally invasive surgery: protocol for the LIVERGREEN phase IV multicentre clinical trial
- There is no consensus on using ICG for liver tumour detection. — Indocyanine green fluorescence for intraoperative detection of liver tumours in minimally invasive surgery: protocol for the LIVERGREEN phase IV multicentre clinical trial
- ICG may support safer hepatic resection by helping with margins, anatomical demarcation, vascularisation, bile leaks, and bile duct localisation. — Indocyanine green fluorescence for intraoperative detection of liver tumours in minimally invasive surgery: protocol for the LIVERGREEN phase IV multicentre clinical trial